Oral mucositis is one of the dose-limiting toxicities of several chemotherapy (CTX) agents.
There are suggested risk factors that could influence the development of mucositis. The …

Background Mucositis is a significant toxicity of cancer therapy with numerous systemic
sequelae. The goal of this systematic review was to update the Multinational Association of …

Purpose The aim of this systematic review was to analyze the available literature and define
clinical practice guidelines for the use of the following agents for the prevention and …

Considerable progress in research and clinical application has been made since the
original guidelines for managing mucositis in cancer patients were published in 2004, and …

Recent research has culminated in convergence of molecular pathobiology with models of
symptom clusters, genetic-based risk, and imaging and computational biology. The field is …

Background Oral mucositis is a side effect of chemotherapy, head and neck radiotherapy,
and targeted therapy, affecting over 75% of high‐risk patients. Ulceration can lead to severe …

OBJECTIVES: To present a clinical update of evidence that applies to the development of a
nursing plan of care for the prevention and treatment of oral mucositis related to cytotoxic …

Oral mucositis is a common, dose limiting and potentially serious complication of both
radiation and chemotherapy. Both these therapies are non-specific, interfering with the …

OBJECTIVES: To review current evidence that applies to the development of a nursing plan
of care for the prevention and treatment of oral mucositis related to cytotoxic therapy. DATA …

Oral and gastrointestinal mucositis caused by high-dose chemotherapy and/or radiation
continues to be an important clinical problem. Fortunately, there have been strategic …